In this episode, Anne MacNeil and Melissa recap day two of the Bio 2025 conference in Boston, discussing the significant themes of licensing and AI in biotech, and the importance of GMPs in research and development. They also touch on global engagement and the need for regulatory help for startups looking to enter the U.S. market.
